{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:04:00Z","timestamp":1788577440801,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf01273159","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T03:16:25Z","timestamp":1111634185000},"page":"627-641","source":"Crossref","is-referenced-by-count":16,"title":["Roxindole, a potential antidepressant I. Effect on the dopamine system"],"prefix":"10.1007","volume":"103","author":[{"given":"J.","family":"Maj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kotodziejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Rog\u00f3\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Skuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01273159_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00518475","volume":"321","author":"N-E And\u00e9n","year":"1982","unstructured":"And\u00e9n N-E, Golembiowska-Nikitin K, Thornstr\u00f6m U (1982) Selective Stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn Schmiedebergs Arch Pharmacol 321: 100\u2013104","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF01273159_CR2","first-page":"41","volume":"276","author":"GD Bartoszyk","year":"1996","unstructured":"Bartoszyk GD, Harting J, Minck KO (1996) Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist. J Pharmacol Exp Ther 276: 41\u201348","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01273159_CR3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2007-1014417","volume":"25","author":"O Benkert","year":"1992","unstructured":"Benkert O, Gr\u00fcnder G, Wetzel H (1992) Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry 25: 254\u2013260","journal-title":"Pharmacopsychiatry"},{"key":"BF01273159_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870080214","volume":"8","author":"D Bravi","year":"1993","unstructured":"Bravi D, Davis TL, Mouradian MM, Chase TN (1993) Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980. Mov Disord 8: 195\u2013197","journal-title":"Mov Disord"},{"key":"BF01273159_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00174869","volume":"338","author":"CLE Broekkamp","year":"1988","unstructured":"Broekkamp CLE, Oosterloo SK, Berendsen HHG, van Delft AML (1988) Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine. Naunyn Schmiedebergs Arch Pharmacol 338: 191\u2013195","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF01273159_CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(72)90277-9","volume":"11","author":"B Costall","year":"1972","unstructured":"Costall B, Naylor RJ (1972) Possible involvement of noradrenergic area of the amygdala with stereotyped behaviour. Life Sci 11 Part I: 1135\u20131146","journal-title":"Life Sci"},{"key":"BF01273159_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0028-3908(68)90022-1","volume":"7","author":"A Delini-Stula","year":"1968","unstructured":"Delini-Stula A, Morpurgo C (1968) Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats. Int J Neuropharmacol 7: 391\u2013397","journal-title":"Int J Neuropharmacol"},{"key":"BF01273159_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/17.2.289","volume":"17","author":"J Gerlach","year":"1991","unstructured":"Gerlach J (1991) New antipsychotics: classification, efficacy, and adverse effects. Schizophr Bull 17: 289\u2013309","journal-title":"Schizophr Bull"},{"key":"BF01273159_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02257418","volume":"111","author":"G Gr\u00fcnder","year":"1993","unstructured":"Gr\u00fcnder G, Wetzel H, Hammes E, Benkert O (1993) Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression. Psychopharmacology 111: 123\u2013126","journal-title":"Psychopharmacology"},{"key":"BF01273159_CR10","first-page":"R 104","volume":"339","author":"J Harting","year":"1989","unstructured":"Harting J, Minck KO (1989) Pharmacological characterization of the dopamine autoreceptor agonist roxindole. Naunyn Schmiedebergs Arch Pharmacol 339: R 104","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"Suppl 4","key":"BF01273159_CR11","first-page":"131","volume":"126","author":"Ch Jaspers","year":"1992","unstructured":"Jaspers Ch, Benker G, Reinhardt W, Cissewski K, Lederbogen S, Schr\u00f6der HG, Reinwein D (1992) A new non-ergot dopamine agonist (roxindol) for treatment of prolactinoma: first results. Acta Endocrinol 126 [Suppl 4]: 131","journal-title":"Acta Endocrinol"},{"key":"BF01273159_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0924-977X(92)90041-6","volume":"2","author":"S Kasper","year":"1992","unstructured":"Kasper S, Fuger J, Zinner HJ, B\u00e4uml J, M\u00f6ller HJ (1992) Early clinical results with the neuroleptic roxindole (EMD 49 980) in the treatment of schizophrenia \u2014 an open study. Eur Neuropsychopharmacol 2: 91\u201395","journal-title":"Eur Neuropsychopharmacol"},{"key":"BF01273159_CR13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.2042-7158.1989.tb06525.x","volume":"41","author":"V Klimek","year":"1989","unstructured":"Klimek V, Maj J (1989) Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2 receptors. J Pharm Pharmacol 41: 555\u2013558","journal-title":"J Pharm Pharmacol"},{"key":"BF01273159_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1014451","volume":"24","author":"A Klimke","year":"1991","unstructured":"Klimke A, Klieser E (1991) Antipsychotic efficacy of the dopaminergic autoreceptor agonist EMD 49980 (roxindol). Pharmacopsychiatry 24: 107\u2013112","journal-title":"Pharmacopsychiatry"},{"key":"BF01273159_CR15","first-page":"99","volume":"96","author":"JT Litchfield","year":"1949","unstructured":"Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01273159_CR16","first-page":"87","volume":"36","author":"J Maj","year":"1984","unstructured":"Maj J (1984) Central effects following repeated treatment with antidepressant drugs. Pol J Pharmacol Pharm 36: 87\u201389","journal-title":"Pol J Pharmacol Pharm"},{"key":"BF01273159_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.2042-7158.1984.tb03011.x","volume":"36","author":"J Maj","year":"1984","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Sowi\u0144ska H (1984) Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol 36: 127\u2013130","journal-title":"J Pharm Pharmacol"},{"key":"BF01273159_CR18","first-page":"133","volume-title":"Neuropharmacology 1985","author":"J Maj","year":"1985","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Sowi\u0144ska H (1985) The effects of repeated treatment with antidepressant drugs on the action of D-amphetamine and apomorphine in rats. In: Kelemen K, Magyar K, Vizi ES (eds) Neuropharmacology 1985. Akad\u00e9miai Kiad\u00f3, Budapest, pp 133\u2013139"},{"key":"BF01273159_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01247108","volume":"78","author":"J Maj","year":"1989","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Sowi\u0144ska H (1989) Antidepressants given repeatedly increase the behavioral effect of dopamine D-2 agonist. J Neural Transm [Gen Sect] 78: 1\u20138","journal-title":"J Neural Transm [Gen Sect]"},{"key":"BF01273159_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0091-3057(76)90037-X","volume":"5","author":"J Maj","year":"1976","unstructured":"Maj J, Sarnek J, Klimek V, Rawl\u00f3w A (1976) On the anticataleptic action of cyproheptadine. Pharmacol Biochem Behav 5: 201\u2013205","journal-title":"Pharmacol Biochem Behav"},{"key":"BF01273159_CR21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"BF01273159_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634146","volume":"50","author":"P Protais","year":"1976","unstructured":"Protais P, Costentin J, Schwartz JC (1976) Climbing behaviour induced by apomorphine in mice: a simple test for the study dopamine receptors in striatum. Psychopharmacology 50: 1\u20136","journal-title":"Psychopharmacology"},{"key":"BF01273159_CR23","first-page":"1147","volume":"263","author":"TA Pugsley","year":"1992","unstructured":"Pugsley TA, Christofferson CL, Corbin A, DeWald HA, Demattos S, Meltzer LT, Myers SL, Shih Y-H, Whetzel SZ, Wiley JN, Wise LD, Heffner TG (1992) Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist. J Pharmacol Exp Ther 263: 1147\u20131158","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01273159_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0024-3205(79)90573-3","volume":"25","author":"G Serra","year":"1979","unstructured":"Serra G, Argiolas A, Klimek V, Fadda F, Gessa GL (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 25: 415\u2013424","journal-title":"Life Sci"},{"key":"BF01273159_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(94)90695-5","volume":"257","author":"ChA Seyfried","year":"1994","unstructured":"Seyfried ChA, Bartoszyk GD (1994) Sensitivity of dopamine D2 receptors following long-term treatment with roxindole. Eur J Pharmacol 257: 67\u201372","journal-title":"Eur J Pharmacol"},{"key":"BF01273159_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(89)90651-1","volume":"160","author":"ChA Seyfried","year":"1989","unstructured":"Seyfried ChA, Greiner HE, Haase AF (1989) Biochemical and functional studies on EMD 49 980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems. Eur J Pharmacol 160: 31\u201341","journal-title":"Eur J Pharmacol"},{"key":"BF01273159_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(81)90531-8","volume":"74","author":"Ch Spyraki","year":"1981","unstructured":"Spyraki Ch, Fibiger HC (1981) Behavioural evidence for supersensivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74: 195\u2013206","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1B","key":"BF01273159_CR28","doi-asserted-by":"crossref","first-page":"175B","DOI":"10.1097\/00002826-199202001-00338","volume":"15","author":"K Wiedemann","year":"1992","unstructured":"Wiedemann K, Kellner M, Krieg J-C, Holsboer F (1992) Effects of the dopamine autoreceptor agonist roxindole in patients with depression. Clin Neuropharmacol 15 [Suppl 1B]: 175B","journal-title":"Clin Neuropharmacol"},{"key":"BF01273159_CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-0173(83)90007-3","volume":"6","author":"P Willner","year":"1983","unstructured":"Willner P (1983) Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res Rev 6: 237\u2013246","journal-title":"Brain Res Rev"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01273159\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:14:35Z","timestamp":1556633675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01273159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF01273159"],"URL":"https:\/\/doi.org\/10.1007\/bf01273159","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}